pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-1303 |
Genomic Coordinates | chr5: 154685776 - 154685861 |
Synonyms | MIRN1303, hsa-mir-1303, MIR1303 |
Description | Homo sapiens miR-1303 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-1303 | ||||||||||||||||||||||||||||||||||||||||||
Sequence | 52| UUUAGAGACGGGGUCUUGCUCU |73 | ||||||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | FAT3 | ||||||||||||||||||||
Synonyms | CDHF15, CDHR10, hFat3 | ||||||||||||||||||||
Description | FAT atypical cadherin 3 | ||||||||||||||||||||
Transcript | NM_001008781 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on FAT3 | |||||||||||||||||||||
3'UTR of FAT3 (miRNA target sites are highlighted) |
>FAT3|NM_001008781|3'UTR 1 ACATCACATCTTGGGTACTTCACCCTGTTTGTTACAGAAAAGTGGAAGCAGATTGGCTGGGCTTCTGTCCCAGTGGAGCA 81 TTGTCTGTGGAATGAGAAGGGAATACTGTATTTTTCCACTAGAAACTTCTTCACAAGTCATACTGTCCCAACAAGCAAGC 161 TTGATTCCAGTTGGGTGAAAATGAAAGGCTCAGAAATTGTTTTTGAGAGGTGACTGGTAATCCTTGATGTAGGTACCTAT 241 GTTCACAGCTAAAAATGCAAAGAGGGAAAAATTATTTCACCCACTAAGTTATACAGCCAGTCTTGTATGGCTTTGTGCAG 321 TATTGTGCCCTGGAAAGTGTTACAGCATCAGTCCTTGCAGTATTAAAAACTGGCAACAATCAAAGAGGCATTGTTGCATG 401 TAATTTTGAGCCAATGAAATGAAAATAGTAGTAATGATTGTTGGAAAAGTTAGTCTCTTAGGCGAAAGAGAAGAGAAACA 481 AATATTATTAAACAAACCAGAAAATGGGCTGAAGCCTTTTAAATCAACTCTATTTTTTTGATAAGCTGCCCAATTTTCAG 561 CTATAAAATTAGGCTTGAATAACATGTTTAGTATGCTCAGTTATTTCTGTTTGTTTGTGTTAAGCATCCAATCTAATATA 641 GTTGGGTTTTATGATCTTCAAGAAAGGTATCAATGAAGAGCAACATGAGGCTTTTTGGGTTCCATTTGGTGGGTGGGGGA 721 GGAAGTTAAAGTTGTTTGAACATTAGAAAGAATGTGATTATCTGGTTGGTTTTGTGTTTTCTGGTAAATATTCCAGTTGG 801 TAAATCTAACATTGCTACAGAAGTTGGCTTTGTTCATATAGCTTCTCTACAATTAGATATTTTTAGAAGTTTAAGCAAAA 881 CTCACAAATTCAGGGGGGAAAAAAGAAAAAACGATACCTTCAAAGTTTGCGGCCTAGATAATCACAATTCTTCATAATGC 961 AGAGGAAAGGTGTCTGTTATTCTAAATCGGTAGCATCACCATTATAAATACAATTATGTTAAGAAAAGAGGAAAGTAGAC 1041 TAGTTATTGTGTATAAATTATAATAGTGTGTGTGTGTCTGGGCCTATGTACAAATATGTGCTTGCACTCAGTAAGGCTGC 1121 TCTTGAGGAAAGCTAATGTGAAGGTTTTGGGAAATGGACCATGTTGAAAATTCTGCCGGCGAGCATGGCATACCTTTCAA 1201 TTTCTCTGATCTCTATGGTGTTAGAGAAACATCAAATGCCATATTTTACTCTGGTTCAGTTAACTTTATTTTGGTACTGC 1281 CAATAAAGCAAAATTGTGCTTTTTTTTTTTTTTCTCAAGACAGAGTCTTGCTCTGTCACCCAGGCTAGAGTGCAATGGCA 1361 TGATCTCAGCTCACTGCAATCTCCACCTCCTGGGTTCAAGCGATTCTCCTGCCTCAGCCTCCCAGGTTGCTGGGGTTACA 1441 GGTGTGTGCCACCACGCCTGGCTAATTTTTTGTATTTTTAGTAGAGATGGGGTTTCACCATGTTGGCCAGGCTGGTCTCA 1521 AACTCCTGACCTCGTAATCCACCTGCCGTGGCCTCCCAAAGTGCTGGGATTACAGGCATGAGCCACCGTGCCCAGCCCAA 1601 AACTGTGCTTTTTAAAAACAGTATTTTGTTATAATTTTCCAGAACTTACCTCTGTTTTAAAAGTGTGTAATGTTTGATTA 1681 CACCCTGGGATTCCCTTCTCATCTGTGGGCTTTGGCCATGATTTCCAAAATTAACAGGAGAATCATTCCACTGGAAATAT 1761 AACAATCCAGTCCTCAAAACTGAAAGTTGACAGGTTGAGGGACTTTCCTTTTTTGCTTCAATCAGATTACGGCCGCCTGT 1841 GCAGTGGCCATGGTAAATATATGCATATTTGCACTATCTGCTTAATGAGCAAATCTGTGTCCACAGTTTCTGATGACATA 1921 TGGCATTGGTGTGTAAATTGTACTGTCCCTAGTCTGTGCATTATTCACTCAGACATATTTTTAGTTATTTCAATTGCGTT 2001 TAATCCACTTCTTTTTTATGAGTCAGTGTTTCTGAATGTTTATGCAAAAAAAAAAATCCTTTTTCATTCCCAAACTTTCT 2081 AAGTAAGTGGATACACTACACTTCACAAGTTTTCCAGCCTTTCTCTTCCTGTCTCTTGGTCAGACCTACTCATGGAGGTA 2161 TTATCCACACTGTGATCTTGAAATAAATGAATTTCACTAAGGCTGCTTTCGAGAACAAAGTCTTTGGTATTTTTCTTATG 2241 TAAGAAGCACATTTGCAAGAATCATGGAAAAAAATGACAAACTAATGGCCTAGAATAGAGTGACTGCTACACTTTAAGTA 2321 ATGCAATGACATAAAAACCATCAAAGTAAAACCAACATGTCATTTCCTGCCCCCAGGAAATATTAGAATGAGATTAATGC 2401 TGATGAGTCCCTACTGCTTACACAGCATCTCTTTGAGGGAGAATGCCTGACTGACACAGTAATGAAAGAATAAATAGATC 2481 CTAATGCAGTCATGAAGCCACTGAAGAAAATTGTGCCCACCCTTTGCTGTGACCTATATAAAATATCTCTTTCTTTGGGA 2561 TATCATCCCCTGATTTTCTGCAGAATAGCTCTGCAGCTAAATATATACCAGGCAAGCATGTATTGTGTTTTGATTTATTA 2641 TCTTTAAACACATGATATCTCTTCACTTTTTGGAAAGTTAGATTTCTCTGTAGATTATGAAATGCTTTGCAGTCAGGCCA 2721 AGATGCTACTAGGTGGGGATGATCACTAATTCAAAAAAGCTGGAAGAATCCTATTTGCTAGTCCAAACTCCTTATTTTAT 2801 CAAAGAGGAAACATACCCAGAGTGGGAAAGAGACTTGCCCAAGCCCACAGAGGAAGTTAATTCGCTTAACAAGGAGTAGA 2881 ACCCATCCATCTAGCCAATATTCTTTTTACATCATATTGTTCACCCCTACACTGCCTTGAGCATGGGAGTCACCTGGTTC 2961 TGATGGACCCTCTGACTTCCACCATTCCTTCTTTGGAATATGCTATAAAAGAAAATTCATGGAGAATATTTTTCTGAAAG 3041 CCTCATGATCTTATGTTTCCTTGCAGTCCCCCTAGGGAGAGGGGTTATAGAATTCATACATTTCTGTAGACATTCATCGA 3121 AATGCTGCTTTTGCCAAATGAATGTTTGTATAATAGGGATGAAATGATAATTACAGAGTTCAGCTCAGACCAGTCATCAG 3201 TTGTAGTGAAACTTTGATTATACTGTTACCTACTGGTTGCATTTTTGGTTTTGGTTTTGCATTTTTTTCTTCCCACAAAC 3281 ACTGGCTACTCTTTGTCCTACCCCCTCCACCATGATGAACCATGTGGAAACTATTTAAATCAATTAATGTCTTTCTCATT 3361 TTTCGAACATGTATGTGCCACCTCCTGGAAGCCATTTCCCATAATCTGTTGTAGGCACTTTACTAGTATTGCACACATTC 3441 TGGTTAGGTTGAGAATAGCTAGACTCTTGGTGCTCGTCATATAGTAAGCAAGAACTTGGGAGTAATAAAAGGTGAATAAA 3521 ATGCATGCTTCATTTATTCCCTTTCCTCTATGAATATTTTGCTGCTGCATTCTAGTCTATGCCAGCTTTCCATGTACCCT 3601 TGGCCTGCCTATTCATGAAATGCCATATAAAAGACTTAGGAACATGAGTAGGTGGTCCATGCTTTGAGGTTCATCCAATT 3681 AGGGAATAAATGTGAAAGGCTGGAAAGGGAACTAGTTTCTGGGATTTGCCTGGAACTTCCCTTGGACATTACTAGCACAT 3761 TCTGGAAAAAAAGCAAGTTGAACATATCTACCATCAGTCCTCTCCTACTTACTTCCCACCCCACCCTATCCACTACCCCC 3841 ACTGATGCTATGTTTGCATCATCAAAGTCAGGGGAATTGAGAAAAGAGATTATCAAAATAAATTATTAAAATCCAGAAAA 3921 CAGTTTTATGTGAAGTAATTCAGGAAGATCTAGTGTTCATTTTGCATGGATTGTCCAGATAATTGGCTCTTCACTCCGCT 4001 GCCTTCCCAGTGCACAGGTATTGCTAAAGTGGTTAGGCTTTAATGTTTTATGTTTTTAGTTTCAAACTATGGGAAATGGA 4081 GATTTGAAGAGGCATTTATTCCTTGTCATCATTTTGTGTGCTCTGTGAGAAGGTGGTTATATGTTTTTGCTGGTTTGTGT 4161 CCCACAGTGTTCAACTGCACATTATTCTGATGAAAATCCACAATGTCTTTGAGCTTCTGGTTGTGTAATGCTGGGGTTTA 4241 AAGTCACCATTTGTGGGTTTGGCATCAATTAATATTTAGCCAGCTGGCTAAGAGATAGGAAAAGAATATGATATTTCTTT 4321 CCTTATGTAATAATGAAAAGCAATAATTACAAGTAGGTAATAATACACAAAGGCCATAATTAGTCTCTTCTAGTGTTTAG 4401 AATGCACTTGAGAATCGTAGAGTCATTTGGAGCGTGTTTGGACCAATTAGTATGTACTGTAGTACCCTTCTGGCAAACAA 4481 ATAACTGAATTGCTACTATTTAACAATCTTATGAGCCCACACTACTGCATTTTGGGAGTGGCAAATGTGTTTGGAAATGG 4561 AAGCAGTTCTTTTTAAGCACTGTATCAGAGAGATTGTCTTGTACGTTTGCCTGTTGCAAACAGGCTGGTTTGTAAAAGAT 4641 GTATGTTTTGGTGTTTGAAATGTTTATAAAATTGTATATAAATGGTTTCAATTTTCCAGGCTTTTGTAGATACTATATTT 4721 GATGCCTATCAGGATGCTTTAATTTGGGGGGTCGAATATAATTGTAAGTCATCCACGCTGTTGGTCTGCAAACTTTTGAG 4801 GTAACTACACACACACACACACACACAAGGATTTTAGATTTGAAAATGATGTTTTTTACTCATTTCAAAATGTACTGTAA 4881 CCTTTCTTTGGTTCTTACTGTTTTCATTTAACTTTCTCTGTTTTCAAGAAAAATTGTCTTTATTGACATTTGTAAAAAAG 4961 AATGTGTTTTGCCCAGTTATTAAGTATTTTATTTTTATGCAATTTCAGAATCACAATGAGGTATGCCATTTCTTCATATA 5041 CATGCACATTCACCTCAACTTGCACACACATCACACACCAAACCTTATGCAAAGGGGAAAGCTAACACTTAGAGTGGATT 5121 TTGTCCCTTAAGGAAATGGATTGTTCCTGCATATATTGCTGGTGGCAGTATTCAGTCTTGTGTTCTTTTTCTAAAAAAAA 5201 AGAAAAGAAAAGAAAAAAAAAACAAAAGCAAACAAAAAAAAAGACAGCCAAAAAAAAGAAACAACAACAACAAAAAAAAA 5281 CACAACAGTGTACAGGTTTGTAACTGCCAAAATTTGATGGTTAAAACAAGTTTTCAAGTAAAAAGAAAAAAATGAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Flp-In T-REx 293-hAGO1 cells |
Location of target site | CDS |
Original Description (Extracted from the article) |
...
Validation of interactions identified by CLASH suppports their reliability.
... - Helwak A; Kudla G; Dudnakova T; Tollervey D, 2013, Cell. |
Article |
- Helwak A; Kudla G; Dudnakova T; Tollervey D - Cell, 2013
MicroRNAs (miRNAs) play key roles in gene regulation, but reliable bioinformatic or experimental identification of their targets remains difficult. To provide an unbiased view of human miRNA targets, we developed a technique for ligation and sequencing of miRNA-target RNA duplexes associated with human AGO1. Here, we report data sets of more than 18,000 high-confidence miRNA-mRNA interactions. The binding of most miRNAs includes the 5' seed region, but around 60% of seed interactions are noncanonical, containing bulged or mismatched nucleotides. Moreover, seed interactions are generally accompanied by specific, nonseed base pairing. 18% of miRNA-mRNA interactions involve the miRNA 3' end, with little evidence for 5' contacts, and some of these were functionally validated. Analyses of miRNA:mRNA base pairing showed that miRNA species systematically differ in their target RNA interactions, and strongly overrepresented motifs were found in the interaction sites of several miRNAs. We speculate that these affect the response of RISC to miRNA-target binding.
LinkOut: [PMID: 23622248]
|
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
186 hsa-miR-1303 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT035871 | SOAT1 | sterol O-acyltransferase 1 | 1 | 1 | ||||||||
MIRT035872 | FHOD3 | formin homology 2 domain containing 3 | 1 | 1 | ||||||||
MIRT035873 | RPL7A | ribosomal protein L7a | 1 | 1 | ||||||||
MIRT035874 | NCAPD2 | non-SMC condensin I complex subunit D2 | 1 | 1 | ||||||||
MIRT035875 | RPS8 | ribosomal protein S8 | 1 | 1 | ||||||||
MIRT035876 | AHNAK | AHNAK nucleoprotein | 1 | 1 | ||||||||
MIRT035877 | ACTB | actin beta | 1 | 1 | ||||||||
MIRT035878 | DEF8 | differentially expressed in FDCP 8 homolog | 1 | 1 | ||||||||
MIRT035879 | MET | MET proto-oncogene, receptor tyrosine kinase | 1 | 1 | ||||||||
MIRT035880 | MED13 | mediator complex subunit 13 | 1 | 1 | ||||||||
MIRT035881 | FAT3 | FAT atypical cadherin 3 | 1 | 1 | ||||||||
MIRT035882 | HUWE1 | HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase | 1 | 1 | ||||||||
MIRT035883 | RPS16 | ribosomal protein S16 | 1 | 1 | ||||||||
MIRT035884 | CDK6 | cyclin dependent kinase 6 | 1 | 1 | ||||||||
MIRT035885 | GEMIN5 | gem nuclear organelle associated protein 5 | 1 | 1 | ||||||||
MIRT035886 | PITRM1 | pitrilysin metallopeptidase 1 | 1 | 1 | ||||||||
MIRT035887 | PRRC2A | proline rich coiled-coil 2A | 1 | 1 | ||||||||
MIRT035888 | KIAA0226 | RUN and cysteine rich domain containing beclin 1 interacting protein | 1 | 1 | ||||||||
MIRT035889 | MLLT6 | MLLT6, PHD finger containing | 1 | 1 | ||||||||
MIRT035890 | EIF3I | eukaryotic translation initiation factor 3 subunit I | 1 | 1 | ||||||||
MIRT035891 | FASN | fatty acid synthase | 1 | 1 | ||||||||
MIRT035892 | LEPREL4 | prolyl 3-hydroxylase family member 4 (non-enzymatic) | 1 | 1 | ||||||||
MIRT035893 | HSCB | HscB mitochondrial iron-sulfur cluster cochaperone | 1 | 1 | ||||||||
MIRT035894 | PSME4 | proteasome activator subunit 4 | 1 | 1 | ||||||||
MIRT035895 | FRS2 | fibroblast growth factor receptor substrate 2 | 1 | 1 | ||||||||
MIRT035896 | ZNF264 | zinc finger protein 264 | 1 | 1 | ||||||||
MIRT035897 | HYLS1 | HYLS1, centriolar and ciliogenesis associated | 1 | 1 | ||||||||
MIRT035898 | USP54 | ubiquitin specific peptidase 54 | 1 | 1 | ||||||||
MIRT035899 | L1TD1 | LINE1 type transposase domain containing 1 | 1 | 1 | ||||||||
MIRT035900 | OR51E2 | olfactory receptor family 51 subfamily E member 2 | 1 | 1 | ||||||||
MIRT053762 | CLDN18 | claudin 18 | 3 | 1 | ||||||||
MIRT060730 | RPS3 | ribosomal protein S3 | 2 | 2 | ||||||||
MIRT083986 | RAB22A | RAB22A, member RAS oncogene family | 2 | 2 | ||||||||
MIRT098550 | TBPL1 | TATA-box binding protein like 1 | 2 | 6 | ||||||||
MIRT134983 | TWF1 | twinfilin actin binding protein 1 | 2 | 4 | ||||||||
MIRT136956 | FNDC3A | fibronectin type III domain containing 3A | 2 | 2 | ||||||||
MIRT222065 | PURB | purine rich element binding protein B | 2 | 2 | ||||||||
MIRT239574 | UBN2 | ubinuclein 2 | 2 | 4 | ||||||||
MIRT261820 | BUB3 | BUB3, mitotic checkpoint protein | 2 | 2 | ||||||||
MIRT264698 | C11ORF57 | chromosome 11 open reading frame 57 | 2 | 4 | ||||||||
MIRT308476 | GXYLT2 | glucoside xylosyltransferase 2 | 2 | 2 | ||||||||
MIRT377481 | NDUFB5 | NADH:ubiquinone oxidoreductase subunit B5 | 2 | 2 | ||||||||
MIRT442304 | NEU3 | neuraminidase 3 | 2 | 2 | ||||||||
MIRT446083 | SLC30A10 | solute carrier family 30 member 10 | 2 | 2 | ||||||||
MIRT449606 | PRPF4 | pre-mRNA processing factor 4 | 2 | 2 | ||||||||
MIRT453767 | NUCB1 | nucleobindin 1 | 2 | 10 | ||||||||
MIRT455603 | SRSF3 | serine and arginine rich splicing factor 3 | 2 | 2 | ||||||||
MIRT455913 | KIF2C | kinesin family member 2C | 2 | 2 | ||||||||
MIRT460091 | ZYG11B | zyg-11 family member B, cell cycle regulator | 2 | 4 | ||||||||
MIRT460866 | UBE2S | ubiquitin conjugating enzyme E2 S | 2 | 2 | ||||||||
MIRT461339 | NUP133 | nucleoporin 133 | 2 | 2 | ||||||||
MIRT463769 | YOD1 | YOD1 deubiquitinase | 2 | 2 | ||||||||
MIRT466368 | THAP1 | THAP domain containing 1 | 2 | 4 | ||||||||
MIRT467168 | SPTY2D1 | SPT2 chromatin protein domain containing 1 | 2 | 2 | ||||||||
MIRT468703 | SDHD | succinate dehydrogenase complex subunit D | 2 | 2 | ||||||||
MIRT469122 | RNF126 | ring finger protein 126 | 2 | 2 | ||||||||
MIRT472426 | NCBP2 | nuclear cap binding protein subunit 2 | 2 | 4 | ||||||||
MIRT479420 | CDKN1B | cyclin dependent kinase inhibitor 1B | 2 | 8 | ||||||||
MIRT484260 | FAM177A1 | family with sequence similarity 177 member A1 | 2 | 2 | ||||||||
MIRT485468 | IL6ST | interleukin 6 signal transducer | 2 | 10 | ||||||||
MIRT490237 | H2AFZ | H2A histone family member Z | 2 | 6 | ||||||||
MIRT491002 | ATF7IP | activating transcription factor 7 interacting protein | 2 | 2 | ||||||||
MIRT492127 | SUMO2 | small ubiquitin-like modifier 2 | 2 | 2 | ||||||||
MIRT499169 | RBPJL | recombination signal binding protein for immunoglobulin kappa J region like | 2 | 2 | ||||||||
MIRT499825 | PCSK9 | proprotein convertase subtilisin/kexin type 9 | 2 | 8 | ||||||||
MIRT501794 | NRAS | NRAS proto-oncogene, GTPase | 2 | 2 | ||||||||
MIRT503441 | GINS4 | GINS complex subunit 4 | 2 | 4 | ||||||||
MIRT503688 | MAVS | mitochondrial antiviral signaling protein | 2 | 5 | ||||||||
MIRT506926 | IGDCC4 | immunoglobulin superfamily DCC subclass member 4 | 2 | 6 | ||||||||
MIRT511430 | HOXA10 | homeobox A10 | 2 | 6 | ||||||||
MIRT512415 | LAYN | layilin | 2 | 4 | ||||||||
MIRT513791 | NIPAL3 | NIPA like domain containing 3 | 2 | 4 | ||||||||
MIRT516163 | NTMT1 | N-terminal Xaa-Pro-Lys N-methyltransferase 1 | 2 | 4 | ||||||||
MIRT516513 | PARK2 | parkin RBR E3 ubiquitin protein ligase | 2 | 2 | ||||||||
MIRT516915 | HINFP | histone H4 transcription factor | 2 | 2 | ||||||||
MIRT517102 | NDUFV3 | NADH:ubiquinone oxidoreductase subunit V3 | 2 | 2 | ||||||||
MIRT517350 | NLRP9 | NLR family pyrin domain containing 9 | 2 | 2 | ||||||||
MIRT518019 | ABHD15 | abhydrolase domain containing 15 | 2 | 2 | ||||||||
MIRT520945 | SRSF10 | serine and arginine rich splicing factor 10 | 2 | 2 | ||||||||
MIRT525250 | RNF213 | ring finger protein 213 | 2 | 2 | ||||||||
MIRT530634 | PPIC | peptidylprolyl isomerase C | 2 | 4 | ||||||||
MIRT530671 | CHRNB1 | cholinergic receptor nicotinic beta 1 subunit | 2 | 4 | ||||||||
MIRT531563 | ILDR1 | immunoglobulin like domain containing receptor 1 | 2 | 2 | ||||||||
MIRT538205 | CYR61 | cysteine rich angiogenic inducer 61 | 2 | 2 | ||||||||
MIRT538419 | COLEC10 | collectin subfamily member 10 | 2 | 2 | ||||||||
MIRT541964 | ZNF485 | zinc finger protein 485 | 2 | 2 | ||||||||
MIRT543088 | KNSTRN | kinetochore localized astrin/SPAG5 binding protein | 2 | 2 | ||||||||
MIRT543257 | ZNF662 | zinc finger protein 662 | 2 | 2 | ||||||||
MIRT543589 | KIAA1549 | KIAA1549 | 2 | 2 | ||||||||
MIRT543955 | RNF20 | ring finger protein 20 | 2 | 2 | ||||||||
MIRT544043 | C9orf64 | chromosome 9 open reading frame 64 | 2 | 4 | ||||||||
MIRT548064 | GIGYF1 | GRB10 interacting GYF protein 1 | 2 | 2 | ||||||||
MIRT548240 | FBXW7 | F-box and WD repeat domain containing 7 | 2 | 2 | ||||||||
MIRT548442 | EIF1AX | eukaryotic translation initiation factor 1A, X-linked | 2 | 2 | ||||||||
MIRT548623 | DAZAP1 | DAZ associated protein 1 | 2 | 4 | ||||||||
MIRT548770 | COLEC12 | collectin subfamily member 12 | 2 | 2 | ||||||||
MIRT549506 | HDDC2 | HD domain containing 2 | 2 | 4 | ||||||||
MIRT551924 | AKAP8 | A-kinase anchoring protein 8 | 2 | 4 | ||||||||
MIRT555656 | PGRMC1 | progesterone receptor membrane component 1 | 2 | 2 | ||||||||
MIRT556286 | MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 2 | 2 | ||||||||
MIRT557012 | HOXD13 | homeobox D13 | 2 | 4 | ||||||||
MIRT563907 | CLSPN | claspin | 2 | 2 | ||||||||
MIRT565527 | SON | SON DNA binding protein | 2 | 2 | ||||||||
MIRT568000 | COMMD2 | COMM domain containing 2 | 2 | 2 | ||||||||
MIRT569831 | PLA2G16 | phospholipase A2 group XVI | 2 | 4 | ||||||||
MIRT573905 | PARP1 | poly(ADP-ribose) polymerase 1 | 2 | 2 | ||||||||
MIRT616589 | KLHL9 | kelch like family member 9 | 2 | 2 | ||||||||
MIRT617137 | ZNF556 | zinc finger protein 556 | 2 | 2 | ||||||||
MIRT617400 | API5 | apoptosis inhibitor 5 | 2 | 2 | ||||||||
MIRT617455 | CCS | copper chaperone for superoxide dismutase | 2 | 2 | ||||||||
MIRT617799 | ZNF793 | zinc finger protein 793 | 2 | 2 | ||||||||
MIRT618190 | MACC1 | MACC1, MET transcriptional regulator | 2 | 2 | ||||||||
MIRT618303 | GNE | glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | 2 | 2 | ||||||||
MIRT618329 | ZNF813 | zinc finger protein 813 | 2 | 2 | ||||||||
MIRT618820 | PHF20 | PHD finger protein 20 | 2 | 2 | ||||||||
MIRT619153 | PPDPF | pancreatic progenitor cell differentiation and proliferation factor | 2 | 2 | ||||||||
MIRT619530 | ZNF708 | zinc finger protein 708 | 2 | 2 | ||||||||
MIRT619849 | KIR3DX1 | killer cell immunoglobulin like receptor, three Ig domains X1 | 2 | 2 | ||||||||
MIRT620806 | SLC26A2 | solute carrier family 26 member 2 | 2 | 2 | ||||||||
MIRT621312 | YIPF4 | Yip1 domain family member 4 | 2 | 2 | ||||||||
MIRT621358 | GUCA1B | guanylate cyclase activator 1B | 2 | 2 | ||||||||
MIRT621366 | ART4 | ADP-ribosyltransferase 4 (Dombrock blood group) | 2 | 2 | ||||||||
MIRT621547 | ZMYM1 | zinc finger MYM-type containing 1 | 2 | 2 | ||||||||
MIRT621883 | TAOK1 | TAO kinase 1 | 2 | 2 | ||||||||
MIRT622451 | RNF19B | ring finger protein 19B | 2 | 2 | ||||||||
MIRT623404 | KREMEN1 | kringle containing transmembrane protein 1 | 2 | 2 | ||||||||
MIRT623587 | IPO9 | importin 9 | 2 | 2 | ||||||||
MIRT623974 | FAM63A | MINDY lysine 48 deubiquitinase 1 | 2 | 2 | ||||||||
MIRT624086 | DPP8 | dipeptidyl peptidase 8 | 2 | 2 | ||||||||
MIRT624108 | DNAH10OS | dynein axonemal heavy chain 10 opposite strand | 2 | 2 | ||||||||
MIRT632486 | RNF8 | ring finger protein 8 | 2 | 2 | ||||||||
MIRT634057 | PLIN3 | perilipin 3 | 2 | 2 | ||||||||
MIRT634657 | GDE1 | glycerophosphodiester phosphodiesterase 1 | 2 | 2 | ||||||||
MIRT640682 | MCUR1 | mitochondrial calcium uniporter regulator 1 | 2 | 2 | ||||||||
MIRT641242 | CENPN | centromere protein N | 2 | 2 | ||||||||
MIRT642260 | ZNF677 | zinc finger protein 677 | 2 | 2 | ||||||||
MIRT642954 | RELA | RELA proto-oncogene, NF-kB subunit | 2 | 2 | ||||||||
MIRT644326 | IPP | intracisternal A particle-promoted polypeptide | 2 | 2 | ||||||||
MIRT644632 | ICA1L | islet cell autoantigen 1 like | 2 | 2 | ||||||||
MIRT645721 | POLR3A | RNA polymerase III subunit A | 2 | 2 | ||||||||
MIRT647850 | LYPLA1 | lysophospholipase I | 2 | 2 | ||||||||
MIRT649281 | NEK8 | NIMA related kinase 8 | 2 | 2 | ||||||||
MIRT650038 | VHL | von Hippel-Lindau tumor suppressor | 2 | 2 | ||||||||
MIRT650354 | RRP36 | ribosomal RNA processing 36 | 2 | 2 | ||||||||
MIRT651144 | ZNF384 | zinc finger protein 384 | 2 | 2 | ||||||||
MIRT651778 | UTP6 | UTP6, small subunit processome component | 2 | 2 | ||||||||
MIRT652576 | TLCD2 | TLC domain containing 2 | 2 | 2 | ||||||||
MIRT654621 | PTPRJ | protein tyrosine phosphatase, receptor type J | 2 | 2 | ||||||||
MIRT656023 | MYO5A | myosin VA | 2 | 2 | ||||||||
MIRT656105 | MSRB3 | methionine sulfoxide reductase B3 | 2 | 2 | ||||||||
MIRT657749 | GMEB1 | glucocorticoid modulatory element binding protein 1 | 2 | 2 | ||||||||
MIRT657924 | GATSL2 | cytosolic arginine sensor for mTORC1 subunit 2 | 2 | 2 | ||||||||
MIRT658848 | DUSP19 | dual specificity phosphatase 19 | 2 | 2 | ||||||||
MIRT659100 | DENND6A | DENN domain containing 6A | 2 | 2 | ||||||||
MIRT659153 | DCX | doublecortin | 2 | 2 | ||||||||
MIRT660870 | ADRBK2 | G protein-coupled receptor kinase 3 | 2 | 2 | ||||||||
MIRT661941 | FAHD1 | fumarylacetoacetate hydrolase domain containing 1 | 2 | 2 | ||||||||
MIRT663577 | C10orf32 | BLOC-1 related complex subunit 7 | 2 | 2 | ||||||||
MIRT664625 | WDPCP | WD repeat containing planar cell polarity effector | 2 | 4 | ||||||||
MIRT666562 | RHOBTB3 | Rho related BTB domain containing 3 | 2 | 2 | ||||||||
MIRT669992 | GPR156 | G protein-coupled receptor 156 | 2 | 4 | ||||||||
MIRT670445 | RSBN1L | round spermatid basic protein 1 like | 2 | 2 | ||||||||
MIRT670853 | IFNAR1 | interferon alpha and beta receptor subunit 1 | 2 | 4 | ||||||||
MIRT671942 | SPPL3 | signal peptide peptidase like 3 | 2 | 2 | ||||||||
MIRT674269 | LMOD3 | leiomodin 3 | 2 | 2 | ||||||||
MIRT674424 | MIOX | myo-inositol oxygenase | 2 | 4 | ||||||||
MIRT674982 | ATP5G1 | ATP synthase, H+ transporting, mitochondrial Fo complex subunit C1 (subunit 9) | 2 | 2 | ||||||||
MIRT675038 | BACE2 | beta-site APP-cleaving enzyme 2 | 2 | 4 | ||||||||
MIRT675309 | C2orf68 | chromosome 2 open reading frame 68 | 2 | 2 | ||||||||
MIRT675641 | TTPAL | alpha tocopherol transfer protein like | 2 | 2 | ||||||||
MIRT688688 | CPS1 | carbamoyl-phosphate synthase 1 | 2 | 2 | ||||||||
MIRT689369 | ZNF101 | zinc finger protein 101 | 2 | 2 | ||||||||
MIRT689605 | AKAP6 | A-kinase anchoring protein 6 | 2 | 2 | ||||||||
MIRT691715 | LARS | leucyl-tRNA synthetase | 2 | 2 | ||||||||
MIRT695473 | TRAT1 | T-cell receptor associated transmembrane adaptor 1 | 2 | 2 | ||||||||
MIRT695530 | MAP4K2 | mitogen-activated protein kinase kinase kinase kinase 2 | 2 | 2 | ||||||||
MIRT695878 | CACNG8 | calcium voltage-gated channel auxiliary subunit gamma 8 | 2 | 2 | ||||||||
MIRT696586 | ORMDL2 | ORMDL sphingolipid biosynthesis regulator 2 | 2 | 2 | ||||||||
MIRT703007 | HEATR5A | HEAT repeat containing 5A | 2 | 2 | ||||||||
MIRT707942 | PHKA1 | phosphorylase kinase regulatory subunit alpha 1 | 2 | 2 | ||||||||
MIRT709765 | GPR183 | G protein-coupled receptor 183 | 2 | 2 | ||||||||
MIRT710332 | ZNF669 | zinc finger protein 669 | 2 | 2 | ||||||||
MIRT713249 | ZFP30 | ZFP30 zinc finger protein | 2 | 2 | ||||||||
MIRT716613 | RBM18 | RNA binding motif protein 18 | 2 | 2 | ||||||||
MIRT733414 | BAG2 | BCL2 associated athanogene 2 | 2 | 0 | ||||||||
MIRT756135 | THSD7A | thrombospondin type 1 domain containing 7A | 3 | 1 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|